mLife (Dec 2022)

MomL inhibits bacterial antibiotic resistance through the starvation stringent response pathway

  • Qin Dou,
  • Jin Yuan,
  • Rilei Yu,
  • Jiahui Yang,
  • Jiayi Wang,
  • Yuxiang Zhu,
  • Jing Zhong,
  • Hongan Long,
  • Zhiqing Liu,
  • Xianghong Wang,
  • Yuying Li,
  • Yichen Xiao,
  • Jiazhen Liang,
  • Xiao‐Hua Zhang,
  • Yan Wang

DOI
https://doi.org/10.1002/mlf2.12016
Journal volume & issue
Vol. 1, no. 4
pp. 428 – 442

Abstract

Read online

Abstract Antibiotic resistance in gram‐negative pathogens has become one of the most serious global public health threats. The role of the N‐acyl homoserine lactone (AHL)‐mediated signaling pathway, which is widespread in gram‐negative bacteria, in the bacterial resistance process should be studied in depth. Here, we report a degrading enzyme of AHLs, MomL, that inhibits the antibiotic resistance of Pseudomonas aeruginosa through a novel mechanism. The MomL‐mediated reactivation of kanamycin is highly associated with the relA‐mediated starvation stringent response. The degradation of AHLs by MomL results in the inability of LasR to activate relA, which, in turn, stops the activation of downstream rpoS. Further results show that rpoS directly regulates the type VI secretion system H2‐T6SS. Under MomL treatment, inactivated RpoS fails to regulate H2‐T6SS; therefore, the expression of effector phospholipase A is reduced, and the adaptability of bacteria to antibiotics is weakened. MomL in combination with kanamycin is effective against a wide range of gram‐negative pathogenic bacteria. Therefore, this study reports a MomL‐antibiotic treatment strategy on antibiotic‐resistant bacteria and reveals its mechanism of action.

Keywords